National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Understanding Cancer Series: HPV Vaccine
< Back to Main
In English En español
    Posted: 06/02/2006    Reviewed: 09/01/2006
Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
PDF Version  View/Print PDF
PowerPoint Version  View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Slide 10 : Pap Test Still Necessary previousnext

After the vaccination, a woman must still get routine Pap tests or another approved cervical cancer screening test. Although the anti-HPV vaccine prevents infection by the dominant HPV types, which are responsible for 70 percent of the cervical cancer cases, it does not prevent infection by most of the other types that can also cause cervical cancer. A Pap test can detect abnormal cervical growth regardless of what HPV type caused it to develop.

Pap Test Still Necessary

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov